Mallinckrodt Inc. Reports Financial Results for Third Fiscal Quarter 2013
8/9/2013 7:03:22 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuticals and global medical imaging business, today reported results for the third quarter of fiscal 2013, ended June 28, 2013.
Net sales were $570.0 million for the third fiscal quarter of 2013, an increase of 10.4%, compared with $516.3 million reported in the third quarter of fiscal 2012.
Hey, check out all the engineering jobs. Post your resume today!
comments powered by